Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors
ConditionHPV Vaccination
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-26
SponsorUniversity of Utah
About this trial
This exploratory mixed-methods study aims to examine receipt of treatment and decision-making among rural cancer patients in Utah. Guided by Conceptual Model of Healthcare Access, the study will integrate, survey and cancer registry data with patient interviews to better understand how travel burden, socioeconomic conditions, health literacy, and other contextual factors shape treatment location and access to care . While the setting of this research is specific to Utah, a state with vast rural regions and only one National Cancer Institute (NCI)-designated cancer center, the findings may inform policy and practice improvements in other states with similar geographic and healthcare infrastructure. Thus, the study has potential relevance for advancing rural cancer equity nationwide.
Understanding how rural cancer patients make treatment decisions is essential to addressing persistent disparities in cancer care access and outcomes. While geographic barriers and structural inequities are well-documented, less is known about the individual and contextual factors that shape patients' choices about where and how to receive treatment. This mixed-methods study will examine receipt of treatment, decision-making, and patient experience among rural cancer patients in Utah, with attention to travel burden, referral pathways, health literacy, and perceived barriers to care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Eligible participants include cancer survivors who are currently ages 18-26 years and who were diagnosed with childhood cancer (ages 0-26 at diagnosis) in the past ten years.
Currently use Facebook or willing to create a Facebook account to use for the duration of the study.
At the time of enrollment, have not completed all recommended doses of the HPV vaccine.
Disqualifiers
Unable to speak and understand English.
Participants who take part in the Aim 1 focus groups will be ineligible for the Aim 2 social media group.
Participants who are fully vaccinated for HPV will be ineligible as the goal of Aim 2 is to evaluate the feasibility of the social media campaign for improving vaccine intention among HPV unvaccinated individuals.
Trial design
Design model
Single group
Treatments tested in this trial
Microvideos: HPV Vaccination Education
BehavioralTo educate survivors of childhood cancers about a key cancer prevention strategy, HPV vaccination. The core microvideos will focus on the 5 Ws of HPV vaccination: Who should get vaccinated, What HPV vaccination protects against, When to get vaccinated, Where to access the vaccine, Why it matters-designed particularly for cancer survivors.
Treatment groups
55 Participants
are divided into 1 treatment groupGroup A: HPV Vaccination EducationOther 1 intervention
Trial outcomes
Primary outcomes
1
Feasibility of Microvideo education
Feasibility will be defined as ≥80% of participants completing the intervention and study surveys.
Time frame
up to 4 weeksSecondary outcomes
1
Acceptability of Microvideo Education
Acceptability will be summarized using means, standard deviations, and proportions of participants indicating strong agreement (scores ≥4 out of 5) with positive statements about the microvideos and platform. Scores range from 0-5, with higher scores indicating more positivity about the microvideos and platform, and lower scores indicating less positivity about the microvideos and platform.
Time frame
up to 4 weeks2
Satisfaction Acceptability of Microvideo Education
Satisfaction will be summarized using means, standard deviations, and proportions of participants indicating strong agreement (scores ≥4 out of 5) with positive statements about the microvideos and platform. Scores range from 0-5, with higher scores indicating more positivity about the microvideos and platform, and lower scores indicating less positivity about the microvideos and platform.
Time frame
up to 4 weeks3
HPV Vaccine Intention
To assess HPV vaccine intention among unvaccinated emerging adult survivors of childhood cancer through a pilot quasi-experimental social media intervention. This outcome measure will report the count of participants who intended to receive the HPV Vaccine after the microvideo education.
Time frame
up to 4 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Utah
Lead sponsor
Prevent Cancer Foundation
Collaborator
Huntsman Cancer Institute
Collaborator
Source ClinicalTrials.gov